Founded in 2004, privately held TechnoVax is a New York metro-area biotechnology company developing viral vaccines through a cell-based virus-like particle platform. Its near-clinical-stage work centers on vaccine candidates for influenza and RSV, including an inhaled powder approach developed with a pulmonary drug-delivery partner. The company also provides biological products and collaborative research services for vaccine, diagnostic, and research applications.
Advanced BioScience Laboratories (ABL), IncFrom its Rockville base, Advanced BioScience Laboratories (ABL) develops and manufactures viral products for vaccines, gene therapies, oncolytic therapies and immunotherapies as a contract development and manufacturing organization. ABL brings more than 60 years of experience working with industry, government and academic partners, including over 30 years focused on viral-vector development and GMP production. Its Rockville facility is ISO 9001 accredited for viral drug-substance and aseptically prepared drug-product manufacturing, and the company has translated more than 100 processes from the laboratory bench into GMP suites.POTOMAC, MD
CastleVax IncLaunched by Mount Sinai in 2022, CastleVax is a clinical-stage vaccine company developing intranasal vaccines with an attenuated Newcastle Disease Virus platform. Its lead candidate, CVAX-01, is a next-generation COVID-19 vaccine designed to stimulate mucosal as well as systemic immunity, while the same platform is being applied to additional respiratory and other infectious diseases. The company’s scientific roots trace to Mount Sinai researchers Peter Palese, Adolfo García-Sastre, Florian Krammer, and Weina Sun.NEW YORK, NY
NovavaxHeadquartered in Gaithersburg, Maryland, Novavax is a biotech company that develops vaccines and vaccine technologies, pairing protein-based nanoparticles with its proprietary Matrix-M® adjuvant. Its platform underpins marketed vaccines for COVID-19 and malaria, while the company continues in-house R&D and works with pharmaceutical, research and government partners to advance additional medicines. Novavax also conducts R&D and Matrix-M manufacturing in Uppsala, Sweden.GAITHERSBURG, MD
Medigen, IncMedigen, Inc. is a biomedical and vaccine company developing vaccines for emerging infectious diseases, chronic diseases including cancer, and other biopharmaceutical applications. Its explicitly described capabilities include vaccine manufacturing, cGMP production of cell and virus banks, virus and protein drug substance production, fill-finish, VLP design and production, molecular biology, electron microscopy, protein expression, and protein purification.FREDERICK, MD